Philippe von Burg

Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)

L. Bubendorf, T. Hermanns, C. Ruiz, 2019, Cancers.

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First‐Line Docetaxel: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial (SAKK 08/11)

J. Bernhard, R. Winterhalder, S. Crabb, 2016, The Prostate.

Pattern of Care Study in Metastatic Renal‐Cell Carcinoma in the Preimmunotherapy Era in Switzerland

F. Stenner, R. Cathomas, J. Beyer, 2018, Clinical genitourinary cancer.

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)

B. Thürlimann, R. Cathomas, P. Bohanes, 2019, Journal of bone oncology.

Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article

T. Winder, D. Helbling, A. Siebenhüner, 2021, Oncology Research and Treatment.

Enzalutamide in Patients With Castration‐Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program

R. Winterhalder, A. Barth, D. Papazoglou, 2017, Clinical genitourinary cancer.